• editor.aipublications@gmail.com
  • Track Your Paper
  • Contact Us
  • ISSN: 2456-8015

International Journal Of Medical, Pharmacy And Drug Research(IJMPD)

In Silico Analysis of the Promoter Regions and Regulatory Elements of DVL2, AXIN1, TCF7 & GSK3B in Triple Negative Breast Cancer

G. Deepthi Reddy , V. Brahmaiah , B. Y. Kavitha , G. Deepika


International Journal of Medical, Pharmacy and Drug Research(IJMPD), Vol-9,Issue-1, January - March 2025, Pages 7-15 , 10.22161/ijmpd.9.1.2

Download | Downloads : 10 | Total View : 1314

Article Info: Received: 29 Jan 2025; Received in revised form: 01 Mar 2025; Accepted: 10 Mar 2025; Available online: 13 Mar 2025

Share

Breast cancers are the leading cause of deaths in women worldwide. Breast cancer majorly occurs in female while some male, about 1% are also affected with this disease. Breast cancers are categorized into four major sub-groups based on the expression of the receptors i.e., Estrogen receptor(ER), Progesterone receptor(PR), and Human epidermal growth factor receptor(HER2) on their cell surface. Among all the sub-groups Triple Negative Breast Cancers are the most aggressive sub-type occurring in premenopausal young women usually below 40years of age. This study is focused on in silico analysis to understand the expression of the genes, it is important to understand the promoter region which plays a key role and to understand the contribution of theses genes in TNBC and the important promoter motifs. The significant promoter motifs that control the transcription of these genes are enumerated below. Studying Single Nucleotide Polymorphisms (SNPs) is critical in genetics for various reasons. SNPs are the most common type of genetic variants in human genome, where a single nucleotide base is altered in the DNA sequence. These variations can have significant impact on the human health, disease susceptibility, drug responses, and evolutionary biology. SNPs or single nucleotide polymorphisms are the changes in the DNA sequences that can have an important role in causing the disease. The SNPs are found in the promoter regions using the tool PredictSNP, and few of them thus found were deleterious. The gene variants plays important role in cancer tumorigenesis, so in this study we have screened promoter regions by using in silico tools to identify SNPs.

Triple Negative Breast Cancer, Single Nucleotide Polymorphisms, DVL2, AXIN1, TCF7, GSK3B.

[1] Bantihun G, Kebede M. In silico analysis of promoter region and regulatory elements of mitogenome co-expressed trn gene clusters encoding for bio-pesticide in entomopathogenic fungus, Metarhizium anisopliae: strain ME1. J Genet Eng Biotechnol. 2021 Jun 22;19(1):94. doi: 10.1186/s43141-021-00191-6. PMID: 34156573; PMCID: PMC8218090.
[2] Aman Beshir J, Kebede M. In silico analysis of promoter regions and regulatory elements (motifs and CpG islands) of the genes encoding for alcohol production in Saccharomyces cerevisiaea S288C and Schizosaccharomyces pombe 972h. J Genet Eng Biotechnol. 2021 Jan 11;19(1):8. doi: 10.1186/s43141-020-00097-9. PMID: 33428031; PMCID: PMC7801573.
[3] Brittney N. Keel, William T. Oliver, John W. Keele, Amanda K. Lindholm-Perry, Evaluation of transcript assembly in multiple porcine tissues suggests optimal sequencing depth for RNA-Seq using total RNA library, Animal Gene, Volumes 17-18, 2020, 200105, ISSN 2352-4065, https://doi.org/10.1016/j.angen.2020.200105. https://www.sciencedirect.com/science/article/pii/S2352406520300051
[4] Liu S, Wang L, Sun N, Yang C, Liu Z, Li X, Cao X, Xu Y, Zhang K. The gender-specific association of rs334558 in GSK3β with major depressive disorder. Medicine (Baltimore). 2017 Jan;96(3):e5928. doi: 10.1097/MD.0000000000005928. PMID: 28099358; PMCID: PMC5279103.
[5] Lin Q, Cao YP, Gao J. Common Polymorphisms in the GSK3β Gene May Contribute to the Pathogenesis of Alzheimer Disease: A Meta-Analysis. J Geriatr Psychiatry Neurol. 2015 Jun;28(2):83-93. doi: 10.1177/0891988714554712. Epub 2014 Oct 27. PMID: 25351705.
[6] Aristizabal-Pachon AF, Castillo WO. Role of GSK3β in breast cancer susceptibility. Cancer Biomark. 2017;18(2):169-175. doi: 10.3233/CBM-160120. PMID: 27983530.
[7] Li W, Gan C, Yu S, Xu J, Tang L, Li Q, Zhu Z, Cheng H. GSK3β rs3107669 polymorphism implicates chemotherapy-associated retrospective memory deficits in breast cancer survivors. Am J Cancer Res. 2023 Oct 15;13(10):4961-4975. PMID: 37970370; PMCID: PMC10636677.
[8] Aristizábal-Pachón AF, Takahashi CS. [Effect of genetics, epigenetics and variations in the transcriptional expression of cadherin-E in breast cancer susceptibility]. Biomedica. 2016 Dec 1;36(4):593-602. Spanish. doi: 10.7705/biomedica.v36i4.3135. PMID: 27992986.
[9] Rosales-Reynoso MA, Zepeda-López P, Saucedo-Sariñana AM, Pineda-Razo TD, Barros-Núñez P, Gallegos-Arreola MP, Flores-Martínez SE, Sánchez-Corona J. GSK3β Polymorphisms Are Associated with Tumor Site and TNM Stage in Colorectal Cancer. Arch Iran Med. 2019 Aug 1;22(8):453-460. PMID: 31679348.
[10] Sayers EW, Bolton EE, Brister JR, Canese K, Chan J, Comeau DC, Connor R, Funk K, Kelly C, Kim S, Madej T, Marchler-Bauer A, Lanczycki C, Lathrop S, Lu Z, Thibaud-Nissen F, Murphy T, Phan L, Skripchenko Y, Tse T, Wang J, Williams R, Trawick BW, Pruitt KD, Sherry ST. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2022 Jan 7;50(D1):D20-D26. doi: 10.1093/nar/gkab1112. PMID: 34850941; PMCID: PMC8728269.
[11] Phan L, Zhang H, Wang Q, Villamarin R, Hefferon T, Ramanathan A, Kattman B. The evolution of dbSNP: 25 years of impact in genomic research. Nucleic Acids Res. 2025 Jan 6;53(D1):D925-D931. doi: 10.1093/nar/gkae977. PMID: 39530225; PMCID: PMC11701571.
[12] Sayers EW, Beck J, Bolton EE, Bourexis D, Brister JR, Canese K, Comeau DC, Funk K, Kim S, Klimke W, Marchler-Bauer A, Landrum M, Lathrop S, Lu Z, Madden TL, O'Leary N, Phan L, Rangwala SH, Schneider VA, Skripchenko Y, Wang J, Ye J, Trawick BW, Pruitt KD, Sherry ST. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2021 Jan 8;49(D1):D10-D17. doi: 10.1093/nar/gkaa892. PMID: 33095870; PMCID: PMC7778943.
[13] Hara A, Lu E, Johnstone L, Wei M, Sun S, Hallmark B, Watkins JC, Zhang HH, Yao G, Chilton FH. Identification of an allele-specific transcription factor binding interaction that regulates PLA2G2A gene expression. bioRxiv [Preprint]. 2023 Dec 13:2023.12.12.571290. doi: 10.1101/2023.12.12.571290. Update in: Bioinform Biol Insights. 2024 Jul 30;18:11779322241261427. doi: 10.1177/11779322241261427. PMID: 38168258; PMCID: PMC10760018.
[14] Burnham KL, Milind N, Lee W, Kwok AJ, Cano-Gamez K, Mi Y, Geoghegan CG, Zhang P; GAinS Investigators; McKechnie S, Soranzo N, Hinds CJ, Knight JC, Davenport EE. eQTLs identify regulatory networks and drivers of variation in the individual response to sepsis. Cell Genom. 2024 Jul 10;4(7):100587. doi: 10.1016/j.xgen.2024.100587. Epub 2024 Jun 18. PMID: 38897207; PMCID: PMC11293594.
[15] Kubota N, Suyama M. An integrated analysis of public genomic data unveils a possible functional mechanism of psoriasis risk via a long-range ERRFI1 enhancer. BMC Med Genomics. 2020 Jan 22;13(1):8. doi: 10.1186/s12920-020-0662-9. PMID: 31969149; PMCID: PMC6977261.
[16] Ferreira JM, Santos BRCD, Moura EL, Santos ACMD, Vencioneck Dutra JC, Figueiredo EVMS, Lima Filho JL. Narrowing the Relationship between Human CCR5 Gene Polymorphisms and Chagas Disease: Systematic Review and Meta-Analysis. Life (Basel). 2023 Aug 2;13(8):1677. doi: 10.3390/life13081677. PMID: 37629534; PMCID: PMC10455882.
[17] Fatemeh S, Mahboobeh Z, Khadijeh A, Amirhossein MK, Pegah M. An in-silico study to determine susceptibility to cancer by evaluating the coding and non-coding non-synonymous single nucleotide variants in the SOCS3 gene. J Biomol Struct Dyn. 2024 Oct;42(16):8281-8292. doi: 10.1080/07391102.2023.2256408. Epub 2023 Sep 27. PMID: 37753777.
[18] Prabhu NB, Vinay CM, Satyamoorthy K, Rai PS. Pharmacogenomics deliberations of 2-deoxy-d-glucose in the treatment of COVID-19 disease: an in silico approach. 3 Biotech. 2022 Nov;12(11):287. doi: 10.1007/s13205-022-03363-4. Epub 2022 Sep 21. PMID: 36164436; PMCID: PMC9491670.
[19] Moraghebi M, Negahi AA, Bazireh H, Abbasi H, Ahmadi M, Sarikhani Z, Mousavi P. The Analysis of SNPs' Function in miR-21 and miR146a/b in Multiple Sclerosis and Active Lesions: An In Silico Study. Bioinform Biol Insights. 2022 Aug 4;16:11779322221116322. doi: 10.1177/11779322221116322. PMID: 35958297; PMCID: PMC9358209.
[20] Dreos R, Ambrosini G, Périer RC, Bucher P. The Eukaryotic Promoter Database: expansion of EPDnew and new promoter analysis tools. Nucleic Acids Res. 2015 Jan;43(Database issue):D92-6. doi: 10.1093/nar/gku1111. Epub 2014 Nov 6. PMID: 25378343; PMCID: PMC4383928.
[21] Dreos R, Ambrosini G, Groux R, Cavin Périer R, Bucher P. The eukaryotic promoter database in its 30th year: focus on non-vertebrate organisms. Nucleic Acids Res. 2017 Jan 4;45(D1):D51-D55. doi: 10.1093/nar/gkw1069. Epub 2016 Nov 28. PMID: 27899657; PMCID: PMC5210552.
[22] Abugessaisa I, Noguchi S, Hasegawa A, Kondo A, Kawaji H, Carninci P, Kasukawa T. refTSS: A Reference Data Set for Human and Mouse Transcription Start Sites. J Mol Biol. 2019 Jun 14;431(13):2407-2422. doi: 10.1016/j.jmb.2019.04.045. Epub 2019 May 8. PMID: 31075273.
[23] Kumar A, Chordia N. In silico PCR primer designing and validation. Methods Mol Biol. 2015;1275:143-51. doi: 10.1007/978-1-4939-2365-6_10. PMID: 25697657.
[24] Kaur S, Bishnoi R, Priyadarshini P, Singla D, Chhuneja P. DSP: database of disease susceptibility genes in plants. Funct Integr Genomics. 2023 Jun 17;23(3):204. doi: 10.1007/s10142-023-01132-x. PMID: 37329484.
[25] Tan C, Chapman B, Wang P, Zhang Q, Zhou G, Zhang XQ, Barrero RA, Bellgard MI, Li C. BarleyVarDB: a database of barley genomic variation. Database (Oxford). 2020 Nov 28;2020:baaa091. doi: 10.1093/database/baaa091. PMID: 33247932; PMCID: PMC7698660.